Comparison of Vehicle Delivery Depth Using the NovoFine® 5 mm Needle With or Without a Skin Fold and Inserted at Either 45 or 90 Degrees

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Diabetes Mellitus
Interventions
PROCEDURE

Sterile air injection

Injection of 20 microlitres using Novofine 5mm needle of sterile air into either abdomen or thigh using either a pinched or unpinched skin fold and either a vertical or angled approach.

PROCEDURE

Placebo injection

Injection of either 20, 40 or 60 IU of placebo media into either abdomen or thigh using either a vertical or angled Novofine 5 mm needle. Leakage of fluid will be blotted and then weighed to establish fluid loss.

DEVICE

Novofine needle

Novofine 5mm needle

Trial Locations (1)

1001

Liggins Institute, Auckland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Liggins Institute

OTHER